• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Joint Public Issues Team

Churches working for peace and justice

  • Home Page
  • Who We Are
    • Six hopes for society
  • Issues
    • Economy
      • Tax Justice
      • Reset The Debt
      • Living Wage
    • Environment
      • Net Zero in My Neighbourhood
    • Poverty and Inequality
      • The Cost of Living Crisis
      • Universal Credit
      • Truth and Lies
      • Enough
      • Rethink Sanctions
      • Faith in Foodbanks
      • Housing and Homelessness
    • Asylum and Migration
      • Refugees
      • End Hostility
      • The Asylum System
    • Peacemaking
      • The Arms Trade
      • Nuclear Weapons
      • Drones
      • Peacemaking resources
    • Politics and Elections
      • General Election manifesto suggestions
      • Elections
      • Meet Your MP
      • Art of the Possible
      • Brexit
    • Other Issues
      • International Development
      • Modern Slavery and Exploitation
        • Forced labour in fashion
  • Get Involved
    • Newsletter
    • Events
  • Resources
    • Advent 2022
    • 10 Minutes on… podcast
    • Newsletter
    • Politics in the Pulpit?
    • Stay and Pray
    • Season of Creation
    • Prayers
    • Public Issues Calendar
    • Poetry
    • Small Group Resources
  • Blog

Vaccinating the World

Blog, COVID-19, Economy, International Development, Poverty and Inequality · 10 December, 2020

As the UK celebrates its first COVID-19 vaccinations, the JPIT enquiry inbox has been receiving emails from church members asking if lower-income nations will be able to access vaccines and, if so, how quickly.

Licencing vaccines

The first hurdle is licencing one or more vaccines for COVID. The UK has given the BioNTech vaccine emergency use authorisation, allowing it to be used widely in the UK.  Low income countries however tend to follow the US and the EU regulators who are (exceptionally quickly) going through their normal processes. This means that they are likely to reach a conclusion in the next few weeks.

It appears likely that other vaccines currently in the development pipeline will be licenced but approval takes time and cannot be guaranteed.

Vaccine cold chains

The BioNTec vaccine needs to be stored at -70oC from manufacture until use – although can be kept in a regular fridge for the final few days before use. This is a difficult cold chain to manage in a high-income country such as the UK and would require considerable time and investment to be workable in many lower-income nations.

The hope is other less temperature sensitive vaccines are licenced and, if so, they are likely to be more useable outside of developed nations. Currently the most promising candidate which doesn’t require such a rigorous cold chain is the Oxford University Adenovirus recombinant.

Buying vaccines – COVAX

The World Health Organisation (WHO) and the UN-backed vaccine alliance (Gavi) alongside, the Coalition for Epidemic Preparedness Innovations (Cepi) set up a program called Covax. Its aim is to ensure equitable worldwide distribution of vaccines by providing collective purchasing facilities and mechanisms to expedite research and manufacture.

The hope was that all nations would join and purchase through the scheme with the higher income countries subsidising the lower-income countries. However, higher-income nations led by the US, Japan and the UK preferred instead to buy direct from manufacturers – guaranteeing rapid supply for their nations.

COVAX aims to have suitable vaccines rolled out simultaneously in developing and developed nations, however it is clear that access to vaccines is going to be massively greater in richer nations for some time. This became inevitable when wealthy nations bought direct from manufacturers rather than through COVAX.

Paying for vaccines

The IMF has estimated that the amount of investment required to counteract COVID’s economic damage is between $9,000Bn and $12,000Bn. The estimated cost of vaccinating the world’s population is around $35Bn – a lot of money, but in economic context an extraordinarily good investment.

COVAX has the objective of supplying 2Bn doses of COVID vaccine and distributing them equitably in 2021. It has raised $2Bn to fund the first stage of the plan – the “advance market commitment” which secures access to vaccine supplies. It requires a further $5Bn in funding over the next year to fund the vaccination program.

Coincidently, just over $5Bn was cut from next year’s International Aid budget when the Government decided to break its commitment to spend 0.7% of GDP on Aid.

The World Bank has offered around $12Bn in loans to pay for vaccination, and other financing is arriving. However, it is clear that countries with few resources have been hit hard by COVID. Additional loans and financing will be needed for rebuilding and development, as well as vaccination. Now is the time when wealthy nations are needed to offer support. It is regrettable that the UK government has chosen to step back and cut funding instead.

Filed Under: Blog, COVID-19, Economy, International Development, Poverty and Inequality

Paul Morrison

I am the policy advisor with particular responsibility for issues around the economy including poverty and inequality. Prior to working for the Methodist Church I was a postdoctoral researcher at Imperial College studying viral disease and vaccine design.

Previous Post: « Advent 2: Wonderful Counsellor
Next Post: Homeless Outreach in the Winter of Coronavirus: Looking to the Future »

Primary Sidebar

Search

Recent Posts

  • COP28 – Benchmarks for success
  • As COP28 approaches
  • The Autumn Statement will not halt growing poverty and destitution
  • Why must every social security announcement feature a big threat?
  • There’s an election coming…
  • The Rwanda plan has failed, but churches can help steer a better course
  • Church leaders respond to net zero announcement
  • Introducing Sienna
  • Introducing Annie
  • Loss and Damage in the run up to COP-28
  • Conflict Prevention and ‘A New Agenda for Peace’
  • The Illegal Migration Bill becomes law
  • Voter ID: the Consequences
  • Why the US should change course on sending cluster munitions to Ukraine
  • Interest rate rises: is there another way?
  • Banning boycotts and divestments – have we not learned anything from South Africa?
  • Sanctions don’t work – but they are increasing anyway
  • Environment Sunday – Hope in the face of Climate Crisis
  • Response to the Government’s White Paper on Gambling
  • 1450+ church leaders oppose the Illegal Migration Bill

Subscribe to our monthly newsletter

Footer

Follow us

  • facebook
  • instagram
  • x
  • youtube

Quick links

Stay and Pray
Politics in the Pulpit
Faith in Politics podcast
Public Issues Calendar
Useful Links

Our work

About Us
Meet the Team
Join the Team 
Internship
Our Newsletter

Contact us

25 Tavistock Place London WC1H 9SF

Tel: 020 7916 8632

enquiries@jpit.uk

Copyright © 2023 · Showcase Pro on Genesis Framework · WordPress · Log in